Entering text into the input field will update the search result below

Veterinary Pain Management Market Is Expecting Huge Revenue Surge By 2023

Dec. 09, 2020 1:41 AM ETZoetis Inc. (ZTS), ELAN, VETOF
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.


  • Increasing Popularity of Non-Conventional and Non-Pharmaceutical Treatment Techniques.
  • Untapped Emerging Markets.

Growth Boosters for Global Veterinary Pain Management Market:

Factors such as growth in companion animal adoption, increasing number of veterinary practitioners and their rising income levels in developed economies, growing prevalence of animal disease causing pain and inflammation, and the rising adoption of pet insurance with growing animal health expenditure are expected to drive the growth of the market.

Years Considered for this Study:

2017 – Base Year

2018 – Estimated Year

2023 – Projected Year

Target Audience:

# Healthcare institutions (hospitals, medical schools, and outpatient clinics)

# Market research and consulting firms

# Venture capitalists and investors

# Research & development companies

# Veterinary pain management manufacturers and distributors

Download PDF Brochure @ Veterinary Pain Management Market

What the Market Looks Like?

The veterinary pain management market is projected to reach USD 1.66 Billion by 2023 from USD 1.13 Billion in 2018, at a CAGR of 8.0% during the forecast period.

Geographical Growth Scenario:

APAC is expected to grow at the highest CAGR during the forecast period.

Global veterinary pain management market has been studied for North America, Europe, Asia Pacific (APAC), Latin America, and Middle East & Africa. APAC is expected to grow at the highest CAGR in veterinary pain management market, primarily due to the significant growth in pet adoption, increasing awareness about animal health, and growing per capita animal health expenditure, especially in India and China.

Global Leaders:

The global veterinary pain management drugs market is a consolidated market, and the top three pharmaceutical companies account for a large share of the global market. Boehringer Ingelheim (Germany), Zoetis (US), Elanco (US), dominated the veterinary pain management drugs market in 2017.

The prominent players in the veterinary pain management market are Zoetis (US), Merck Animal Health (US), Elanco (US), Chanelle (Ireland), Boehringer Ingelheim (Germany), Vetoquinol (France), Bayer (Germany), Norbrook (Ireland), Ceva Santé Animale (France), K-Laser (US), Assisi (US), and Dechra Pharmaceuticals (UK). New product launches and acquisitions were the major strategies adopted by these payers to maintain their positions in the veterinary pain management market

Talk to Our Experts for More Details@ Veterinary Pain Management Market

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.